• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液学患者在化疗及自体干细胞移植预处理期间的非转铁蛋白结合铁

Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation.

作者信息

Sahlstedt Leila, von Bonsdorff Leni, Ebeling Freja, Parkkinen Jaakko, Juvonen Eeva, Ruutu Tapani

机构信息

Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.

出版信息

Eur J Haematol. 2009 Nov;83(5):455-9. doi: 10.1111/j.1600-0609.2009.01310.x. Epub 2009 Jul 1.

DOI:10.1111/j.1600-0609.2009.01310.x
PMID:19572995
Abstract

Free iron induced hydroxyl radical formation is one possible mechanism for tissue injury during cytotoxic therapy. We studied the appearance of free, non-transferrin-bound iron (NTBI) at baseline and during the 20-d period after the onset of cytotoxic chemotherapy in patients with haematological malignancy undergoing intensive chemotherapy or conditioning for autologous stem cell transplantation (aSCT). NTBI was detected on average for 15.6 d in patients treated with chemotherapy only, and for 6.1 d in patients undergoing aSCT. The recovery of the bone marrow function coincided with the disappearance of NTBI. The type of the conditioning regimen was also associated with the appearance of NTBI. The timing of the presence of NTBI accords with the presence of the most important non-infectious complication of intensive chemotherapy and autologous transplantation, mucosal injury, and free iron is likely to contribute to this and probably other complications of the intensive treatments.

摘要

游离铁诱导的羟基自由基形成是细胞毒性治疗期间组织损伤的一种可能机制。我们研究了血液系统恶性肿瘤患者在接受强化化疗或自体干细胞移植(aSCT)预处理时,基线及细胞毒性化疗开始后20天内游离的、非转铁蛋白结合铁(NTBI)的出现情况。仅接受化疗的患者中NTBI平均检测到15.6天,接受aSCT的患者中为6.1天。骨髓功能的恢复与NTBI的消失同时发生。预处理方案的类型也与NTBI的出现有关。NTBI出现的时间与强化化疗和自体移植最重要的非感染性并发症——黏膜损伤的出现时间一致,游离铁可能导致这种情况以及强化治疗的其他并发症。

相似文献

1
Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation.血液学患者在化疗及自体干细胞移植预处理期间的非转铁蛋白结合铁
Eur J Haematol. 2009 Nov;83(5):455-9. doi: 10.1111/j.1600-0609.2009.01310.x. Epub 2009 Jul 1.
2
[Late infectious complications after high-dose therapy and autologous blood stem cell transplantation].[大剂量治疗及自体造血干细胞移植后的晚期感染并发症]
Med Klin (Munich). 2002 Nov 15;97(11):650-8. doi: 10.1007/s00063-002-1208-y.
3
Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications.急性白血病患者在整个传统强化化疗过程中的非转铁蛋白结合铁(NTBI):其出现的动力学及在感染并发症中的潜在预测作用
Leuk Res. 2015 Jan;39(1):88-91. doi: 10.1016/j.leukres.2014.11.003. Epub 2014 Nov 15.
4
Effect of repeated apotransferrin administrations on serum iron parameters in patients undergoing myeloablative conditioning and allogeneic stem cell transplantation.多次给予脱铁转铁蛋白对接受清髓性预处理和异基因干细胞移植患者血清铁参数的影响。
Br J Haematol. 2006 Oct;135(2):228-34. doi: 10.1111/j.1365-2141.2006.06273.x. Epub 2006 Aug 22.
5
Myocardial release of non-transferrin-bound iron during cardio-pulmonary bypass surgery.体外循环心脏手术期间心肌释放非转铁蛋白结合铁
J Med. 1999;30(3-4):157-67.
6
Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia.持续输注伊达比星和静脉注射白消安作为急性髓性白血病患者自体干细胞移植的预处理方案。
Hematol Oncol. 2009 Dec;27(4):198-202. doi: 10.1002/hon.903.
7
Factors influencing haematological recovery following high-dose chemotherapy and peripheral stem-cell transplantation for haematological malignancies; 1-year analysis.影响血液系统恶性肿瘤大剂量化疗及外周血干细胞移植后血液学恢复的因素;1年分析
Eur J Cancer. 2004 May;40(8):1199-207. doi: 10.1016/j.ejca.2004.01.029.
8
Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT).与血清铁蛋白相比,非转铁蛋白结合铁(NTBI)对异基因干细胞移植(ASCT)后结局的影响。
Ann Hematol. 2017 Aug;96(8):1379-1388. doi: 10.1007/s00277-017-3034-6. Epub 2017 Jun 6.
9
Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.白消安和环磷酰胺(Bu/Cy)作为非霍奇金淋巴瘤患者自体干细胞移植的预处理方案:单中心经验
Biol Blood Marrow Transplant. 2009 Nov;15(11):1447-54. doi: 10.1016/j.bbmt.2009.07.014. Epub 2009 Sep 1.
10
Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.在存在不饱和转铁蛋白的情况下对非转铁蛋白结合铁进行定量分析。
Anal Biochem. 1999 Sep 10;273(2):212-20. doi: 10.1006/abio.1999.4216.

引用本文的文献

1
Iron as an emerging therapeutic target in critically ill patients.铁作为危重症患者的一个新兴治疗靶点。
Crit Care. 2023 Dec 4;27(1):475. doi: 10.1186/s13054-023-04759-1.
2
Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications.医学中的铁负荷毒性:从分子和细胞角度到临床意义。
Int J Mol Sci. 2023 Aug 18;24(16):12928. doi: 10.3390/ijms241612928.
3
Unbalance in Iron Metabolism in Childhood Leukemia Converges with Treatment Intensity: Biochemical and Clinical Analysis.儿童白血病铁代谢失衡与治疗强度相关:生化与临床分析
Cancers (Basel). 2021 Jun 17;13(12):3029. doi: 10.3390/cancers13123029.
4
Iron overload in the HCT patient: a review.HCT 患者的铁过载:综述。
Bone Marrow Transplant. 2021 Aug;56(8):1794-1804. doi: 10.1038/s41409-021-01244-7. Epub 2021 Mar 29.
5
Iron overload in transfusion-dependent patients.输血依赖患者的铁过载。
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):337-344. doi: 10.1182/hematology.2019000036.
6
Improved survival outcomes and restoration of graft-vs-leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia.异基因造血干细胞移植后地拉罗司改善急性髓系白血病的生存结局并恢复移植物抗白血病效应。
Cancer Med. 2019 Feb;8(2):501-514. doi: 10.1002/cam4.1928. Epub 2019 Jan 24.
7
The Tumor Suppressor, P53, Decreases the Metal Transporter, ZIP14.肿瘤抑制因子 P53 降低金属转运蛋白 ZIP14。
Nutrients. 2017 Dec 8;9(12):1335. doi: 10.3390/nu9121335.
8
Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.镰状细胞贫血慢性输血患儿的器官铁蓄积:TWiTCH试验的基线结果
Br J Haematol. 2016 Jan;172(1):122-30. doi: 10.1111/bjh.13791. Epub 2015 Nov 2.
9
Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.成人异基因造血细胞移植后高血铁蛋白血症:通过测定无转铁蛋白结合铁来量化铁负荷。
Int J Hematol. 2013 Jan;97(1):125-34. doi: 10.1007/s12185-012-1252-1. Epub 2012 Dec 23.
10
Treating thalassemia major-related iron overload: the role of deferiprone.治疗重型地中海贫血相关的铁过载:去铁酮的作用
J Blood Med. 2012;3:119-29. doi: 10.2147/JBM.S27400. Epub 2012 Oct 19.